At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Penicillins
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 06 Dec 2000 Profile reviewed but no significant changes made
- 31 Aug 1998 No-Development-Reported for HIV-1 infections in United Kingdom (Unknown route)
- 21 Sep 1995 New profile